Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$126.1M
+1304.0% from 2023
Prescriptions
2,394
$52,674.07 per claim
Patients
658
480 prescribers
Total spending, 2024
$126.1M
$191,643.96 per patient
Medicare prescription drug plans paid $126.1M for Vyvgart Hytrulo in 2024, for 2,394 prescriptions and refills to 658 patients (up 1304.0% from 2023). The average cost per claim was $52,674.07.
Florida had the highest Medicare cost for Vyvgart Hytrulo in 2024: $13.6M for 251 claims, followed by California ($12.6M).
Mario Vukic, neurology in Hackensack, NJ, had the highest Medicare cost for Vyvgart Hytrulo in 2024: 45 claims costing $2.6M.
Vyvgart Hytrulo is made by argenx SE (ARGX), listed in the Medicare spending data as Argenx US, Inc.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Mario Vukic Hackensack, NJ | Neurology | 45 | 12 | $2.6M |
| Samir P Macwan Rancho Mirage, CA | Neurology | 42 | Under 11 | $2.1M |
| Rocio C Garcia Santibanez |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2023 | 78 | 170 | 86 | $9.0M |
| 2024 | 480 | 2,394 | 658 | $126.1M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims |
|---|
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Neurology |
| 27 |
| Under 11 |
| $1.6M |
| Jeffrey D Miles Huntington, WV | Neurology | 25 | Under 11 | $1.6M |
| Michael H Rivner Macon, GA | Neurology | 25 | Under 11 | $1.5M |
| Michael T Pulley Jacksonville, FL | Neurology | 23 | Under 11 | $1.4M |
| Alyson L Hommel Wilmington, NC | Neurology | 24 | Under 11 | $1.4M |
| Ali A Habib Orange, CA | Neurology | 22 | Under 11 | $1.3M |
| Allan S Weiss Saint Petersburg, FL | Neurology | 21 | Under 11 | $1.2M |
| Susanne Gonzalez-Gallardo Houston, TX | Neurology | 19 | Under 11 | $1.2M |
| Mark A Landrio Winchester, VA | Neurology | 19 | Under 11 | $1.1M |
| Andreas D Runheim Winston-Salem, NC | Neurology | 17 | Under 11 | $1.0M |
| Michael C Slama Brighton, MA | Neurology | 15 | Under 11 | $970K |
| Thomas H Brannagan III New York, NY | Neurology | 26 | Under 11 | $968K |
| Jason Heil Cincinnati, OH | Neurology | 15 | Under 11 | $916K |
| Ning S Yang Johnstown, CO | Neurology | 15 | Under 11 | $861K |
| Amanda L Witt Jackson, MS | Physical Medicine and Rehabilitation | 13 | Under 11 | $860K |
| Ravi A Patel Apple Valley, CA | Neurology | 13 | Under 11 | $795K |
| Chelsea A Shugars Chattanooga, TN | Neurology | 14 | Under 11 | $775K |
| Michael K Hehir II Burlington, VT | Neurology | 12 | Under 11 | $764K |
| Robert S Meadows Winston Salem, NC | Neurology | 12 | Under 11 | $744K |
| Mohammad Alsharabati Palos Heights, IL | Neurology | 20 | Under 11 | $744K |
| Pushpa Narayanaswami Boston, MA | Neurology | 12 | Under 11 | $743K |
| Christina Chrisman Phoenix, AZ | Neurology | 12 | Under 11 | $737K |
| Raghav Govindarajan O Fallon, IL | Neurology | 12 | Under 11 | $732K |
| Spending |
|---|
| Argenx US, Inc ARGX | 2,394 | $126.1M |